Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-13BBIO144KUMAR HALDEA FAMILY IRREVOCABLE TRUST plan to sell securities of BridgeBio Pharma, Inc. under Form 144MEDIUM
KUMAR HALDEA FAMILY IRREVOCABLE TRUST filed Form 144 to notify SEC of plan to sell 140000 units of BridgeBio Pharma, Inc. securities around 2026-03-13, with aggregate market value of $9,517,200.00. The total outstanding units is 193862871.0. The amount planned to be sold represents 0.07% of total outstanding units; Rec...
Large CapBiotechnology
2026-03-13LQDA144Rajeev Saggar plan to sell securities of LIQUIDIA CORPORATION under Form 144MEDIUM
Rajeev Saggar filed Form 144 to notify SEC of plan to sell 35365 units of LIQUIDIA CORPORATION securities around 2026-03-13, with aggregate market value of $1,283,834.38. The total outstanding units is 88114429.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in past 3 m...
Mid CapBiotechnology
2026-03-13LQDA144RAMANDEEP SINGH plan to sell securities of LIQUIDIA CORPORATION under Form 144MEDIUM
RAMANDEEP SINGH filed Form 144 to notify SEC of plan to sell 40359 units of LIQUIDIA CORPORATION securities around 2026-03-13, with aggregate market value of $1,457,296.50. The total outstanding units is 88114429.0. The amount planned to be sold represents 0.05% of total outstanding units; ...
Mid CapBiotechnology